Paper6961973
Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.
Nelson JA and 2 others. Cancer Chemother Pharmacol, 1982. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma. Papers, record 6961973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6961973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melphalan | Major topic |
| Osteosarcoma | Major topic |
| Vincristine | Major topic |
| Analysis of Variance | |
| Animals | |
| Dose-Response Relationship, Drug | |
| Male | |
| Mice | |
| Mice, Inbred AKR | |
| Neoplasm Transplantation | |
| Sarcoma, Experimental |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-16672 | NCI NIH HHS | United States | P01CA016672 | PubMed and NIH | NIH RePORTER |
| CA-28034 | NCI NIH HHS | United States | R01CA028034 | PubMed and NIH | NIH RePORTER |
| P30CA016672 | NIH | NIH RePORTER |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7044517 | Favorable factors in the adjuvant therapy of breast cancer. | Cancer | 1982 | https://conductscience.org/library/papers/7044517 | PubMed |
| 2 | 4499910 | Combination chemotherapy for spontaneous AKR lymphoma. | Cancer Chemother Rep 2 | 1974 | https://conductscience.org/library/papers/4499910 | PubMed |
| 3 | 7248979 | Biological and experimental consequences of the zonal composition of solid tumors. | Cancer Res | 1981 | https://conductscience.org/library/papers/7248979 | PubMed |
| 4 | 1260756 | Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma. | Cancer Res | 1976 | https://conductscience.org/library/papers/1260756 | PubMed |
| 5 | 14221786 | PERSPECTIVES IN CANCER CHEMOTHERAPY: THERAPEUTIC DESIGN. | Cancer Res | 1964 | https://conductscience.org/library/papers/14221786 | PubMed |
| 6 | 4644205 | Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine. | Cancer Res | 1972 | https://conductscience.org/library/papers/4644205 | PubMed |
| 7 | 710805 | Mechanism of natural resistance of rat ascites hepatomas to 1-beta-D-arabinofuranosylcytosine. | Gan | 1978 | https://conductscience.org/library/papers/710805 | PubMed |
| 8 | 7390894 | Concurrent and subsequent tumors in the same host: a model to evaluate the host tumor interaction. | Int J Radiat Oncol Biol Phys | 1980 | https://conductscience.org/library/papers/7390894 | PubMed |
| 9 | 6947891 | Concepts for controlling drug-resistant tumor cells. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6947891 | PubMed |
| 10 | 354778 | Tumor heterogeneity and the biology of cancer invasion and metastasis. | Cancer Res | 1978 | https://conductscience.org/library/papers/354778 | PubMed |
| 11 | 4827349 | On the presence within tumours of clones that differ in sensitivity to cytostatic drugs. | Acta Pathol Microbiol Scand A | 1974 | https://conductscience.org/library/papers/4827349 | PubMed |
| 12 | 6961973 | Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6961973 | PubMed |
| 13 | 698935 | Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. | Cancer Res | 1978 | https://conductscience.org/library/papers/698935 | PubMed |
| 14 | 5670719 | Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster. | Cancer Chemother Rep | 1968 | https://conductscience.org/library/papers/5670719 | PubMed |
| 15 | 6994913 | The practical benefits of pharmacokinetics in the use of antineoplastic agents. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6994913 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15256002 | The influence of tumor size and environment on gene expression in commonly used human tumor lines. | BMC Cancer | 2004 | https://conductscience.org/library/papers/15256002 | PubMed |
| 6961973 | Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6961973 | PubMed |
| 3690803 | Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3690803 | PubMed |
| 3470163 | Changing metastatic patterns of a transplantable rat osteosarcoma. | Clin Exp Metastasis | 1987 | https://conductscience.org/library/papers/3470163 | PubMed |
| 3409443 | Variability of tumor response to chemotherapy. II. Contribution of tumor heterogeneity. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3409443 | PubMed |
| 1568290 | Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1568290 | PubMed |
| 1348974 | Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1348974 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6961973
GET https://conductscience.org/api/papers/v1/6961973/authors